The downexpression of these miRNAs significantly reduced cancer cell proliferation and apoptosis by targeting FOXO-3, CLSPN, ACVR1B, E2F4 and PPP2CA and regulated cell cycle progression by targeting CDKN2A and FOXO-3 (Fig. 5A). Here, CDKN2A is linked to cancer.